Bridgeway Capital Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-128,000
| Closed | -$1.82M | – | 1316 |
|
|
2019
Q1 | $1.82M | Buy |
128,000
+65,000
| +103% | +$925K | 0.02% | 563 |
|
|
2018
Q4 | $178K | Sell |
63,000
-25,000
| -28% | -$70.6K | ﹤0.01% | 1235 |
|
|
2018
Q3 | $304K | Hold |
88,000
| – | – | ﹤0.01% | 1252 |
|
|
2018
Q2 | $282K | Hold |
88,000
| – | – | ﹤0.01% | 1262 |
|
|
2018
Q1 | $216K | Buy |
88,000
+38,000
| +76% | +$93.3K | ﹤0.01% | 1263 |
|
|
2017
Q4 | $280K | Hold |
50,000
| – | – | ﹤0.01% | 1228 |
|
|
2017
Q3 | $278K | Buy |
+50,000
| New | +$278K | ﹤0.01% | 1220 |
|